Molecular analysis of premalignant and carcinoma in situ lesions of the human breast.
作者信息
Steeg P S, Clare S E, Lawrence J A, Zhou Q
机构信息
Women's Cancers Section, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
出版信息
Am J Pathol. 1996 Sep;149(3):733-8.
Abstract
摘要
相似文献
1
Molecular analysis of premalignant and carcinoma in situ lesions of the human breast.人乳腺癌前病变和原位癌的分子分析
Am J Pathol. 1996 Sep;149(3):733-8.
2
Molecular evidence for progression of microglandular adenosis (MGA) to invasive carcinoma.微腺性腺病（MGA）进展为浸润性癌的分子证据。
Am J Surg Pathol. 2009 Apr;33(4):496-504. doi: 10.1097/PAS.0b013e31818af361.
3
Microsatellite alterations on human chromosome 11 in in situ and invasive breast cancer: a microdissection microsatellite analysis and correlation with p53, ER (estrogen receptor), and PR (progesterone receptor) protein immunoreactivity.原位和浸润性乳腺癌中人类11号染色体的微卫星改变：显微切割微卫星分析及其与p53、雌激素受体（ER）和孕激素受体（PR）蛋白免疫反应性的相关性
J Surg Oncol. 2000 Jun;74(2):100-7. doi: 10.1002/1096-9098(200006)74:2<100::AID-JSO5>3.0.CO;2-O.
4
Ductal carcinoma in situ of the breast: correlation between histologic classifications and biologic markers.乳腺导管原位癌：组织学分类与生物学标志物之间的相关性
Mod Pathol. 1997 Nov;10(11):1088-92.
5
The p53 tumor suppressor gene in ductal carcinoma in situ of the breast.乳腺导管原位癌中的p53肿瘤抑制基因。
Am J Pathol. 2000 Jan;156(1):5-6. doi: 10.1016/S0002-9440(10)64698-6.
6
[Transplantation of human primary in-situ and invasive breast carcinoma in nude mice].
Zhonghua Zhong Liu Za Zhi. 1996 Sep;18(5):321-3.
7
8
Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.微小腺腺病及向原位癌和浸润癌转变的临床、组织病理学及免疫组化特征。
Am J Surg Pathol. 2008 Apr;32(4):544-52. doi: 10.1097/PAS.0b013e31815a87e2.
9
10
Prostatic intraepithelial neoplasia. Relationship to adenocarcinoma of prostate.前列腺上皮内瘤变。与前列腺腺癌的关系。
Pathol Annu. 1994;29 ( Pt 2):1-30.
引用本文的文献
1
Lactation-induced WAP-SV40 Tag transgene expression in C57BL/6J mice leads to mammary carcinoma.哺乳期诱导的WAP-SV40 Tag转基因在C57BL/6J小鼠中的表达会导致乳腺癌。
Transgenic Res. 1998 Jul;7(4):253-63. doi: 10.1023/a:1008865911660.
本文引用的文献
1
Pattern of gene alterations in intraductal breast neoplasms associated with histological type and grade.与组织学类型和分级相关的乳腺导管内肿瘤的基因改变模式。
Clin Cancer Res. 1995 Mar;1(3):261-7.
2
Antigen-presenting cell engineering. The molecular toolbox.抗原呈递细胞工程。分子工具箱。
Am J Pathol. 1996 Jan;148(1):1-16.
3
The modulation of thrombospondin and other naturally occurring inhibitors of angiogenesis during tumor progression.
Breast Cancer Res Treat. 1995;36(2):119-26. doi: 10.1007/BF00666034.
4
Allelic loss on a chromosome 17 in ductal carcinoma in situ of the breast.乳腺导管原位癌中17号染色体上的等位基因缺失。
Cancer Res. 1993 Jul 1;53(13):2947-9.
5
Oestrogen receptor expression in ductal carcinoma in situ of the breast: relationship to flow cytometric analysis of DNA and expression of the c-erbB-2 oncoprotein.乳腺导管原位癌中雌激素受体的表达：与DNA流式细胞术分析及c-erbB-2癌蛋白表达的关系。
Br J Cancer. 1993 Jul;68(1):156-61. doi: 10.1038/bjc.1993.305.
6
p53 protein expression in mammary ductal carcinoma in situ: relationship to immunohistochemical expression of estrogen receptor and c-erbB-2 protein.乳腺导管原位癌中p53蛋白表达：与雌激素受体及c-erbB-2蛋白免疫组化表达的关系
Hum Pathol. 1993 May;24(5):463-8. doi: 10.1016/0046-8177(93)90157-c.
7
8
Correlations between the mammographic features of ductal carcinoma in situ (DCIS) and C-erbB-2 oncogene expression. Nottingham Breast Team.导管原位癌（DCIS）的乳腺钼靶特征与C-erbB-2癌基因表达之间的相关性。诺丁汉乳腺团队。
Clin Radiol. 1994 Aug;49(8):559-62. doi: 10.1016/s0009-9260(05)82937-x.
9
Identification of genes expressed in premalignant breast disease by microscopy-directed cloning.通过显微镜引导克隆鉴定癌前乳腺疾病中表达的基因。
Proc Natl Acad Sci U S A. 1994 Sep 27;91(20):9257-61. doi: 10.1073/pnas.91.20.9257.
Zotero 插件